文献速递系统性红斑狼疮其他结缔组织病

系统性红斑狼疮相关纯红细胞再生障碍:全国回顾性队列与文献综述

Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该全国多中心回顾性队列纳入24例经骨髓检查确诊并排除细小病毒B19感染的SLE相关PRCA成人患者,描述其临床生物学过程、治疗及应答。结果显示PRCA为严重并发症,多数需反复输血及多线免疫抑制治疗,严重感染和铁过载风险高,尽管多数患者最终获得持续应答,最佳治疗策略仍待确定。

要点

  • SLE相关PRCA病情严重,87%患者需红细胞输注,75%发生需住院的严重感染。
  • 79%患者需免疫抑制治疗且方案高度异质,糖皮质激素仅3例获持续完全应答。
  • 中位随访76个月,71%完全应答、21%部分应答、8%治疗失败。

核心结论

  • SLE相关PRCA是严重并发症,常需反复红细胞输注和多线免疫抑制治疗,严重感染与铁过载风险高。
  • 尽管多数患者PRCA和SLE获得持续应答,最佳治疗策略仍待确定。

研究设计与样本

  • 全国多中心回顾性队列研究,2006至2018年纳入24例经骨髓检查确诊PRCA且符合SLE或SLE生物学表现、并排除细小病毒B19感染的成人患者。

主要发现

  • 24例患者中20例为女性;14例PRCA诊断前已确诊SLE,中位间隔81个月。
  • PRCA诊断时平均年龄39.2(13.2)岁,血红蛋白62(20)g/l,网织红细胞9.1(7.6)×10^9/l,有核红细胞分类计数2.8(2.5)%。
  • 11例(45%)经历多次PRCA复发,中位6次(范围2-11)。
  • 中位随访76个月(范围13-173)后,17例(71%)完全应答、5例(21%)部分应答、2例(8%)治疗失败。
  • 21例(87%)需红细胞输注,5例诊断输血相关铁过载;18例(75%)发生需住院的严重感染事件。

关键数值与推荐

  • 糖皮质激素治疗仅3例获得持续完全应答。
  • 19例(79%)需免疫抑制药物,方案高度异质。

临床怎么用

  • 对SLE患者出现贫血且网织红细胞不低时,应警惕PRCA并完善骨髓检查,同时排除细小病毒B19感染。
  • 治疗需兼顾PRCA与SLE活动,注意反复输血所致铁过载及免疫抑制相关严重感染风险。

局限性

  • 回顾性设计且样本量小(24例),治疗方案高度异质,无法确定最佳治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize the clinical and biological course, management and response to treatment in SLE-associated pure red cell aplasia (PRCA). METHODS: This was a nationwide, multicentre, retrospective cohort study. From 2006 to 2018, we included adults with a diagnosis of PRCA supported by bone marrow examination and SLE or biologic manifestations of SLE after ruling out parvovirus B19 infection. RESULTS: We enrolled 24 patients (20 women). SLE was diagnosed before PRCA for 14 patients (median delay 81 months). At PRCA diagnosis, mean age, haemoglobin level, and reticulocyte and differential erythroblast count were 39.2 (13.2) years, 62 ( 20) g/l, 9.1 (7.6) × 109/l and 2.8 ( 2.5)%, respectively. Eleven (45%) patients experienced multiple PRCA flares (median 6, range 2-11). CS therapy resulted in only three complete sustained responses, and 19 (79%) patients required immunosuppressive agents with highly variable regimens. After a median follow-up of 76 months (range 13-173), 17 (71%) patients showed complete response for PRCA, 5 (21%) partial response and 2 (8%) treatment failure. In total, 21 (87%) patients required red blood cell transfusion; 5 had a diagnosis of transfusion-related iron overload. Eighteen (75%) patients experienced severe infectious events requiring hospitalization. CONCLUSION: SLE-associated PRCA is a severe condition. Repeated red blood cell transfusions and several lines of immunosuppressant therapy are mostly required, with high risk of severe infectious events and iron overload. Despite sustained response for PRCA and SLE obtained in most patients, the best therapeutic strategy remains to be determined.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lobbes H, Mahévas M, Alviset S, et al. Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature. Rheumatology (Oxford). 2021. PMID: 33871586. doi:10.1093/rheumatology/keab363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。